Abstract
The site of treatment failureincluded the abdomen alone in 48% of patients, and only4% developed distant metastatic site alone. Thus, there is astrong rationale for extensive locoregional treatmentcombining cytoreductive surgery and perioperative intra-peritoneal chemotherapy to treat a locoregional disease.Long-term survival has already been reported for perito-neal dissemination of various etiologies treated with thisaggressive but comprehensive combined therapeuticapproach.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
